Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Fountain Valley › NPI 1497702575
Hospital

Orange Coast Memorial Medical Center

Orange Coast Memorial Medical Center was paid $4.92M by Medicaid between Jan 2018 and Dec 2024, across 220 billing codes. Its largest line is 0450, Emergency room services — 9.5% of everything it billed.

33Billing provider infoORANGE COAST MEMORIAL MEDICAL CENTER
FOUNTAIN VALLEY, CA 92708
33aNPI1497702575assigned 05/27/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.92M
24GClaims604,017
24DCodes billed220
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#228 of 410
Median peer was paid$6.90M
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201882,252$597K
201978,428$737K
202090,265$671K
202199,759$592K
2022113,960$705K
202397,374$817K
2024incomplete41,979$799K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 9.5% 44,999 38,881 $468K
74177 Computed tomography, abdomen and pelvis; with contrast material 7.6% 4,443 3,997 $373K
A0429 Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) 6.5% 7,751 4,761 $321K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 5.6% 12,105 10,409 $274K
G0378 Hospital observation service, per hour 5.1% 1,096 734 $249K
0202U Oncology (prostate), multianalyte, gene expression profiling 4.1% 1,288 1,259 $201K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3.7% 4,175 3,993 $182K
96375 Therapeutic injection; each additional sequential IV push 3.2% 10,820 8,337 $157K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.8% 17,870 15,672 $138K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2.7% 7,365 6,739 $135K
80053 Comprehensive metabolic panel 2.6% 31,354 26,276 $127K
74176 Computed tomography, abdomen and pelvis; without contrast material 2.5% 2,592 2,359 $124K
208 more codes
70450 Computed tomography, head or brain; without contrast material 2.5% 4,848 $124K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.1% 4,495 $103K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.0% 33,945 $97K
96361 Intravenous infusion, hydration; each additional hour 1.7% 9,627 $85K
J7030 Infusion, normal saline solution , 1000 cc 1.6% 16,480 $79K
J3490 Unclassified drugs 1.5% 26,587 $74K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1.5% 7,851 $72K
71045 Radiologic examination, chest; single view 1.4% 14,466 $68K
71275 Computed tomographic angiography, chest, with contrast material 1.3% 742 $65K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.2% 6,204 $57K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.2% 1,719 $57K
36430 <1% 376 $49K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 3,213 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 2,056 $46K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,557 $44K
93971 <1% 829 $43K
84484 <1% 11,593 $40K
99199 Unlisted special service, procedure or report <1% 1,173 $40K
83880 <1% 3,752 $37K
J7050 Infusion, normal saline solution, 250 cc <1% 11,716 $36K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 7,291 $35K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 1,257 $34K
99285 Emergency room visit (most serious) <1% 4,156 $34K
83690 <1% 11,558 $31K
99283 Emergency room visit (moderate) <1% 3,525 $30K
96376 <1% 4,371 $29K
Z9725 <1% 915 $27K
84145 <1% 3,035 $25K
83605 <1% 5,830 $23K
72125 Computed tomography, cervical spine; without contrast material <1% 598 $23K
76830 Ultrasound, transvaginal <1% 829 $22K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 630 $22K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,368 $17K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 11,605 $16K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 446 $15K
36415 Collection of venous blood by venipuncture <1% 21,882 $15K
99284 Emergency room visit (serious) <1% 2,350 $14K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,371 $13K
P9016 Red blood cells, leukocytes reduced, each unit <1% 347 $11K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,602 $11K
A9585 Injection, gadobutrol, 0.1 ml <1% 883 $11K
J2785 Injection, regadenoson, 0.1 mg <1% 353 $11K
93970 <1% 211 $11K
81025 <1% 6,203 $11K
85379 <1% 2,397 $11K
78815 Positron emission tomography (PET) for limited area imaging <1% 498 $10K
70551 Magnetic resonance imaging, brain; without contrast material <1% 372 $10K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 83 $10K
82803 <1% 2,679 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,928 $10K
71250 <1% 377 $9K
82533 <1% 1,715 $9K
80305 <1% 1,508 $9K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,354 $9K
87040 <1% 1,947 $9K
C1769 Guide wire <1% 79 $9K
36416 <1% 4,201 $8K
81003 <1% 10,104 $8K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 264 $8K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 883 $8K
80048 Basic metabolic panel (calcium, ionized) <1% 4,468 $8K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 344 $8K
73630 <1% 783 $7K
81001 <1% 6,293 $7K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 90 $7K
0710 <1% 2,037 $7K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,210 $7K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 473 $6K
97162 <1% 536 $6K
73030 <1% 717 $6K
73610 <1% 522 $5K
85610 <1% 5,111 $5K
90715 <1% 295 $5K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries <1% 566 $5K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 173 $5K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 172 $5K
84703 <1% 3,006 $5K
Z7502 <1% 122 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,087 $4K
85730 <1% 2,849 $4K
J2060 Injection, lorazepam, 2 mg <1% 2,074 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 1,703 $4K
82947 <1% 8,456 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 118 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,506 $4K
83735 <1% 2,151 $4K
0270 <1% 23,552 $4K
73562 <1% 459 $4K
0370 <1% 1,358 $4K
76801 <1% 120 $4K
0272 <1% 4,247 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,017 $4K
93017 <1% 517 $3K
73564 <1% 286 $3K
96367 <1% 285 $3K
J2704 Injection, propofol, 10 mg <1% 3,635 $3K
85027 <1% 2,251 $3K
71046 Radiologic examination, chest; 2 views <1% 599 $3K
87186 <1% 1,090 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 525 $3K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 26 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,307 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,625 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 597 $2K
84443 Thyroid stimulating hormone (TSH) <1% 569 $2K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 349 $2K
0160 <1% 1,891 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 474 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,488 $2K
83874 <1% 546 $2K
73110 <1% 191 $2K
86923 <1% 340 $2K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 14 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 229 $2K
86901 <1% 2,546 $2K
J1815 Injection, insulin, per 5 units <1% 1,555 $2K
86900 <1% 2,553 $2K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,740 $2K
84702 <1% 517 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 41 $2K
87088 <1% 688 $2K
73130 <1% 164 $2K
36592 <1% 67 $2K
87077 <1% 640 $2K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,931 $2K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,989 $2K
0250 <1% 20,850 $1K
70496 <1% 13 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 690 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 98 $1K
J7042 5% dextrose/normal saline (500 ml = 1 unit) <1% 725 $1K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 829 $1K
77067 Screening mammography, bilateral, including computer-aided detection <1% 66 $1K
59025 Fetal non-stress test <1% 143 $1K
72131 <1% 36 $1K
87486 <1% 83 $1K
J1644 Injection, heparin sodium, per 1000 units <1% 1,210 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 513 $1K
86140 <1% 584 $1K
80143 <1% 115 $1K
87581 <1% 83 $996.76
80179 <1% 114 $993.73
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 83 $887.20
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,506 $885.00
86850 <1% 1,512 $879.90
84100 <1% 711 $872.24
71010 <1% 109 $774.28
82550 <1% 373 $767.00
0949 <1% 486 $526.23
S0164 Injection, pantoprazole sodium, 40 mg <1% 144 $476.36
J3370 Injection, vancomycin hcl, 500 mg <1% 94 $412.59
76775 <1% 27 $352.73
80061 Lipid panel <1% 124 $337.01
76642 <1% 14 $327.08
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 12 $280.53
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12 $279.63
85007 <1% 215 $228.00
72100 <1% 27 $215.74
72141 <1% 13 $205.07
85652 <1% 173 $201.99
0301 <1% 1,042 $191.85
74018 <1% 27 $167.50
70486 <1% 13 $164.00
0360 <1% 260 $149.17
73080 <1% 14 $148.59
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 312 $133.81
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 38 $123.41
J3475 Injection, magnesium sulfate, per 500 mg <1% 49 $99.49
80047 <1% 42 $98.05
J0360 Injection, hydralazine hcl, up to 20 mg <1% 70 $96.61
29515 <1% 16 $84.00
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 14 $78.21
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 12 $69.61
82728 <1% 41 $68.61
A9573 Injection, gadopiclenol, 1 ml <1% 27 $67.34
74240 <1% 51 $61.92
87147 <1% 30 $58.65
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program <1% 2,503 $54.55
29125 <1% 14 $44.01
87205 <1% 29 $43.24
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 13 $41.65
0300 <1% 152 $34.10
A4217 Sterile water/saline, 500 ml <1% 31 $32.20
51702 <1% 22 $30.10
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 13 $27.77
J1171 Injection, hydromorphone, 0.1 mg <1% 38 $25.68
82565 <1% 28 $24.03
85014 <1% 57 $22.51
77063 Screening digital breast tomosynthesis, bilateral <1% 16 $22.33
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 18 $10.81
97116 <1% 14 $7.96
0351 0% 33 $0.00
0302 0% 79 $0.00
0760 0% 236 $0.00
0320 0% 99 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 49 $0.00
0402 0% 89 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 26 $0.00
0762 0% 20 $0.00
0306 0% 247 $0.00
0636 0% 401 $0.00
0305 0% 456 $0.00
0720 0% 40 $0.00
0352 0% 133 $0.00
0307 0% 78 $0.00
0258 0% 58 $0.00
0324 0% 151 $0.00
0379 0% 57 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMCNAMARA, STEVE (CHIEF FINANCIAL OFFICER)